Public Profile

CM Life Sciences III Inc.

CM Life Sciences III Inc., headquartered in the United States, is a prominent player in the life sciences investment sector. Founded in 2021, the company focuses on identifying and partnering with innovative businesses in the biotechnology and healthcare industries. With a strategic emphasis on transformative technologies, CM Life Sciences III aims to drive advancements in areas such as therapeutics and diagnostics. The firm distinguishes itself through its robust investment approach, leveraging deep industry expertise to support the growth of its portfolio companies. Notable achievements include successful mergers and acquisitions that enhance its market position. As a key participant in the life sciences space, CM Life Sciences III Inc. is committed to fostering innovation and delivering value to stakeholders while navigating the dynamic landscape of healthcare advancements.

DitchCarbon Score

How does CM Life Sciences III Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

CM Life Sciences III Inc.'s score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

CM Life Sciences III Inc.'s reported carbon emissions

CM Life Sciences III Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures regarding their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may still be in the early stages of developing its climate commitments or reporting frameworks. Without concrete information on their carbon footprint or reduction initiatives, it is unclear how CM Life Sciences III Inc. is addressing climate change or contributing to sustainability efforts within the industry.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CM Life Sciences III Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CM Life Sciences III Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CM Life Sciences III Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers